This November, we’re heading to landmark events to connect with theranostics pioneers and the global radiopharmacy community.

NOAR Europe Annual Meeting | Nantes, November 3-5

We’ll be attending the first annual NOAR Europe 2025 conference at Onepoint in Nantes—a pioneering event fully dedicated to astatine-211 (At-211) and its growing potential in targeted alpha therapy.

More info about the conference : https://astatine-net.eu/news/noar-europe-annual-meeting-from-3-to-5-november-2025-in-nantes/

SNMMI Theranostics Conference | Bethesda, MD, November 6-8

Trasis team at SNMMI Theranostics Conference

Our team will be at the Bethesda North Marriott Hotel & Conference Center for this premier educational meeting bringing together leading experts across the full theranostics spectrum, from current clinical practice to emerging innovations.

7th Targeted Radiopharmaceuticals Summit Europe | Amsterdam, November 11-12

Trasis team at TRP Summit Europe November 2025

In Amsterdam, we will join over 200 leaders in radiopharmaceutical therapy development for the 7th edition of the TRP Summit Europe.

Our CDMO offering spans radiosynthesis automation on our widely adopted synthesizer platforms trusted by leading RLT developers, API precursor development, aseptic production, and delivery of ready-to-use kits, cassettes, and precursors for radiopharmaceutical projects.

Accelerating the Radiotracers of today and tomorrow

We’ll showcase how Trasis helps teams move faster from innovative idea to clinical impact across the full production workflow:

Automated synthesis platforms empowering the “see & treat” concept, designed for diverse isotopes and chemistries, covering both therapeutic and diagnostic needs
Streamline™ cassettes and reagent solutions to compress R&D cycles and de-risk scale-up for both diagnostic and therapeutic agents
Comprehensive CDMO services: radiosynthesis automation, API precursor development, aseptic production, manufacturing of ready-to-use cassettes and reagent kits and sterile fill-finish, to support all your projects from early research through preclinical and clinical phases
QC1: our compact and integrated quality control instrument, streamlining batch release while minimizing operator exposure
SteriNow®: on-site direct automated, cassette-based sterility test sample preparation – designed to eliminate radioactivity interference, cutting delay and exposure while ensuring compliance.

Related contents

Trasis simplifies your radiopharmaceutical QC - from batch release to sterility testing

Trasis Innovation Newsletter - March 2025